2 of the Best TSX Growth Stocks to Buy Before July Ends

These two TSX growth stocks look worth buying in July after their recently started recovery.

| More on:

The TSX Composite Index just posted its biggest weekly gains in nearly 17 months with the help of a sharp recovery in some high-growth tech stocks. Despite continued inflationary pressures and a rising interest rate environment, investors’ high expectations from tech companies’ upcoming earnings could be one of the reasons for a sharp recovery in these growth stocks. That’s why it could be the right time for growth investors to act now and add some of these fundamentally strong stocks to their portfolios, as they have the potential to yield outstanding returns as their recovery begins.

In this article, I’ll highlight two of the best TSX growth stocks you can consider buying in July.

Descartes Systems stock

Descartes Systems Group (TSX:DSG)(NASDAQ:DSGX) is a Waterloo-based software company with a market cap of about $7.5 billion. Its software solutions primarily focus on improving the productivity and performance of logistics-related businesses. While its stock trades at $87.96 per share with 16% year-to-date losses, it has risen by 10% in July so far amid the recently started tech sector-wide recovery.

In the April quarter, Descartes Systems registered a 7.6% YoY (year-over-year) rise in its total revenue to US$116.4 billion as the demand for its software services strengthened amid the continued global supply chain crisis. During the quarter, its adjusted earnings also jumped by 28.6% YoY to $0.27 per share.

In order to accelerate its sales growth further, the tech firm is continuing to focus on new acquisitions. For example, Descartes recently acquired a Utah-based e-commerce shipping solutions provider, XPS Technologies, in a deal worth US$65 million (excluding potential performance-based consideration). Most of Descartes’s recent quality acquisitions are likely to help expand its global market share and accelerate its financial growth further in the long term. Given these positive factors, Canadian investors could consider buying this TSX growth stock before July ends.

Nuvei stock

Nuvei (TSX:NVEI)(NASDAQ:NVEI) could be another quality growth stock to consider in July. Shares of this Montréal-based payment technology company have seen 44% value erosion in 2022 so far. Nonetheless, NVEI stock staged a sharp recovery last week by jumping nearly 14% to $45.70 per share — possibly due to investors’ rising expectations from its upcoming earnings report.

The ongoing growth trend in Nuvei’s financials remains strong, as it registered a 43.1% YoY surge in its total sales in the March quarter to US$214.5 million. Increasing demand for its innovative payment platform amid reopening economies also drove its adjusted net profit up by 35% YoY to US$69.1 million for the quarter. Interestingly, the e-commerce segment made up nearly 88% of its total volume in Q1, reflecting consistent growth in digital commerce adoption in the post-pandemic era.

As Nuvei continues to advance its strategic initiatives by supporting more digital and fiat currencies on its platform, I expect its sustainable and profitable growth trends to remain intact in the coming years. Given these positive factors, long-term investors may consider buying this TSX growth stock right now after its recently started rally.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool has positions in and recommends Nuvei Corporation. The Motley Fool recommends DESCARTES SYS and Descartes Systems Group. Fool contributor Jitendra Parashar has no position in any of the stocks mentioned.

More on Tech Stocks

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

profit rises over time
Tech Stocks

2 Non-AI Tech Stocks to Buy in November for Better Returns

Not all AI stocks are riding the hype train, and for many investors, well-understood and predictable growth stocks might be…

Read more »

worry concern
Tech Stocks

In a Few Years, You’ll Probably Regret Not Owning BlackBerry Stock

Here’s why I believe BlackBerry could be one of the most overlooked Canadian tech stocks right now.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

Is Constellation Software Stock a Buy for its 0.25% Dividend Yield?

Here's what investors may want to consider when it comes to Dollarama (TSX:DOL) and its relatively low dividend yield.

Read more »

Nurse talks with a teenager about medication
Tech Stocks

Shares of WELL Health Just Zoomed. Is It a Buy?

Given its improving financials and healthy growth prospects, WELL Health could deliver superior returns over the next three years.

Read more »